Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 

Rise of
+0.15 (+1.00%) Merck & Company - [Ticker: MRK]Chart Merck & Company  News Merck & Company  Download Historical Prices for Metastock Merck & Company and Others  Technical Analysis Merck & Company  
Last Trade79.37Last Trade Time2018-12-04 - 00:00:00
Variation+0.15 (+1.00%)Open79.30
High80.19Low79.18
Volume4,330,639Average Volume (3m)0
YieldBid / Ask55.43 x 900 - 55.44 x 2,100
Former Close79.2252 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Merck & Company -  [Ticker: MRK] chart
Change to Merck & Company Interactive Technical Analysis Chart

Last 10 Forum Topics about Merck & Company:
No topics about Merck & Company [MRK] have been found, but a search on the Forum for more topics related to Merck & Company is advised.

 News about Merck & Company [MRK]:   (ordered by relevance)
  1. Merck takes aim at Pfizer?s Covid pill as concerns linger over its own drug  Financial Times
  2. Pfizer and Merck Covid-19 Pills Are Coming Soon in the U.S., but Other Countries Will Have to Wait  The Wall Street Journal
  3. Merck's New Covid Pill  Bloomberg
  4. Pfizer and Merck covid-19 pills are coming soon in the US, but other countries will have to wait  Livemint
  5. Merck says its COVID-19 drug should be effective against any variant  Reuters
  1. Merck taps Thermo Fisher to manufacture COVID pill in Canada for global rollout push  FiercePharma
  2. Canada to manufacture Merck COVID-19 antivirals if regulator approves  Cranbrook Townsman
  3. Merck ties up with Thermo Fisher to make its COVID-19 pill in Canada  Reuters
  4. Merck to make its COVID-19 antiviral pill in Canada, company announces  Global News
  5. Canada prepared to manufacture Merck COVID antivirals | Canada's National Observer: News & Analysis  National Observer
Merck's Hilleman Laboratories tees up $58M investment at new Singapore vaccine hub  FiercePharma Here's Why Merck Lost Nearly $40 Billion in Value During November  The Motley Fool Merck's Keytruda Nets Another Win in Melanoma  BioSpace Carisma Therapeutics Announces Collaboration with Merck to Evaluate CAR-Macrophages in Combination with KEYTRUDA® (pembrolizumab) in a Clinical Study  PRNewswire NGM Bio Announces Clinical Trial Collaboration with Merck Related to Ongoing Phase 1/2 Trial of ...  The Baytown Sun Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?  Forbes IO Biotech collaborates with Merck to evaluate IO102-IO103 + Keytruda in three tumor types  Seeking Alpha Merck says its Covid antiviral treatment less effective than first thought  Financial Times Merck Pausing Enrollment for Two Trials of Oral Islatravir  MarketWatch UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report  Hindustan Times Merck seeks approval of first oral COVID drug in Japan  The Japan Times Why molnupiravir could still work for Merck  Vantage EU recommends Merck COVID-19 pill for adults at risk of severe illness  Reuters FDA Action Alert: Daré, Reata, Merck and Amgen  BioSpace U.K. Set to Deploy Merck's Covid Pill in 10000-Person Study  Bloomberg South Africa in Talks With Pfizer, Merck for Covid Pills  Bloomberg Buffett's Berkshire exited Merck investment just before COVID pill boost, further trimmed AbbVie and BMS holdings  FiercePharma Stocks making the biggest moves midday: Twitter, Moderna, Merck, Tesla and more  CNBC Merck Closes Deal for Acceleron Pharma, Biggest Biotech Merger of the Year  Barron's Merck Reports Pause Of Enrollment In 2 Phase 3 Trials Of Its Oral Islatravir For Pre-Exposure Prophylaxis Of HIV-1 Infection  Benzinga Merck Announces First-Quarter 2022 Dividend  Business Wire EU to advise on Merck's COVID-19 pill in "shortest possible" time  Reuters Pfizer, like Merck, inks deal to license COVID-19 pill and boost global supply  FiercePharma Merck & Co., Inc. (MRK) Stock: Do Analysts Think You Should Buy?  InvestorsObserver Belgium in talks to buy 10000 doses of Merck's COVID-19 pill, health minister says  Reuters Merck's Covid Pill Partner in India Sees a Short-Lived Boom  Bloomberg Merck signs strategic agreement with GI Innovation to develop biomedicine  Korea Biomedical Review Merck buzzes Dragonfly for 2nd immunotherapy candidate in $700M pact month after Bristol Myers' 6th opt-in  FierceBiotech Merck expects Covid pill to reach rich and poor countries simultaneously  FRANCE 24 Merck HIV combo sees approval chances soar to 99%: regulatory roundup  Clinical Trials Arena Pfizer boosts Paxlovid manufacturing capacity as Merck's rival COVID pill hits surprise efficacy setback  FiercePharma Merck says making progress on meeting surge in lab gear demand  Reuters COVID-19 live updates: Canada plans to manufacture Merck antivirals; Alberta Omicron case count climbs to 12; Ten cases found on Norwegian Cruise ship  Edmonton Journal Is Merck Stock a Buy?  Motley Fool Better Buy: Bristol Myers Squibb vs. Merck  Nasdaq Merck KGaA, Darmstadt, Germany Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus  Business Wire Merck on trends in oncology: the pharmaphorum podcast -  pharmaphorum Merck's Keytruda opens new blockbuster frontier with FDA approval in post-surgery kidney cancer  FiercePharma Merck and Ridgeback to Present Phase 3 Data for Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, at American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meeting  Business Wire Italy to acquire 50000 courses for each of Merck, Pfizer COVID-19 antiviral drugs  Reuters Better COVID Stock: Merck vs. Pfizer  Motley Fool Here's Why Merck Stock Vaulted Higher in October  The Motley Fool FBI launches probe after 'SMALLPOX is found in Merck facility while cleaning out a freezer'  Daily Mail Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted  Reuters UPDATED: Biogen pulls PRIME designation for aducanumab in Europe; Merck closes merger with Acceleron  Endpoints News As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea  FierceBiotech Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate  GlobeNewswire Merck's Plan B Percolates After Pfizer Announces Dominance  Seeking Alpha Months after a Merck spinout, Organon continues its string of deals with a $954M buyout package  Endpoints News Merck signs pact to broaden generic manufacturing of COVID-19 pill  Reuters Merck potential animal health spin could be next after J&J split up  Seeking Alpha FDA expected to approve Pfizer and Merck antiviral pills  The Washington Post How Will Merck's Stock Forecast Be Impacted By U.K.'s COVID Pill Authorization?  Seeking Alpha Merck looks to ditch the needles with its next-gen oral PCSK9 inhibitor for high cholesterol  Endpoints News Merck COVID-19 pill sparks calls for access for lower income countries  Reuters Merck Announces Initiation of Phase 3 Study Evaluating VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction Who Have Not Had a Recent Worsening Heart Failure Event  Yahoo Finance A new boss, a new path forward and new challenges for N.J. pharma giant  nj.com Covid News: U.S. to Tighten Testing for Travelers Amid Omicron Worries  The New York Times Merck & Co. Inc. stock underperforms Wednesday when compared to competitors  MarketWatch Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths  Reuters Merck to buy Acceleron Pharma for $11.5bn  Financial Times Merck to collaborate with Ontada on data-driven cancer insights  OutSourcing-Pharma.com Merck on deals hunt as patent cliff looms for top cancer drug  Financial Times Merck, Evidation join forces on Alzheimer's data solutions  OutSourcing-Pharma.com Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop  The Guardian Pfizer, Merck launch new trials of oral COVID-19 drugs  Reuters Can Merck's new boss maintain the drugmaker's winning streak?  The Economist What?s Next For Merck Stock After A 5% Fall In A Week?  Forbes Merck KGaA, GSK end partnership on former cancer drug hopeful  Reuters Merck's Gesture to Save Humanity From COVID-19  Fair Observer U.S. signs $1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug  Reuters Merck develops new technology to address solubility and speed to market challenges of ADCs  BioPharma-Reporter.com Merck completes new $116m viral vector manufacturing facility  Cleanroom Technology UK creates deal for 480,000 doses of Merck COVID pill  Open Access Government Merck KGaA says lab supplies business can grow by up to 10% per year  Reuters A bear and a bull debate the move in health care after Merck?s Covid pill breakthrough  CNBC Merck KGaA's new CEO shakes up U.S. leadership to spark sales of promising drugs  FiercePharma Merck drug less effective against moderate COVID -India regulatory source  Reuters With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision  Forbes Merck Sales Beat Estimates, But the Stock Fell. Here?s 1 Reason to Be Bullish.  Barron's Merck will support Saudi Arabia effort to build biologics manufacturing operations  FiercePharma EU Panel May Start Accelerated Review of Merck's Covid Pill  Bloomberg Merck strikes deal for global access to Covid drug  FRANCE 24 Merck taps Xeris for ready-to-use versions of antibody products  FiercePharma U.S. drugmaker Merck sees bigger hit to full-year sales from pandemic  Reuters WHO says seeks more data from Merck on COVID anti-viral, from Bharat on vaccine  Reuters Merck to continue tests of Covid pill, but stop trial in hospitalized patients  STAT Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds  FiercePharma Merck, Codexis extend supply deal for key API in Januvia, Janumet  FiercePharma Merck and Singapore sign deal on COVID-19 antiviral pill  Reuters Merck Announces Appointment of Head of China & International for Healthcare  Business Wire Merck rolls out new lipid technology ahead of schedule  BioPharma-Reporter.com Merck to Spend $3.5 Billion on Electronics Unit Amid Chip Crunch  Bloomberg Merck Announces Completion of Organon & Co. Spinoff  Business Wire Merck begins late-stage trial of experimental COVID-19 drug  Reuters Merck's Welireg scores FDA nod in cancers spurred by rare disease?and its label is broader than expected  FiercePharma Merck spin-off Organon sees share price jump at Q2 results  PMLiVE Merck ups single-use product assembly with $30m expansion in France  Cleanroom Technology
For more news about Merck & Company click here:
Merck & Company News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources